From Gastrointestinal Graft-vs-Host Disease to Crohn Disease and Back Again: A Diagnostic Challenge in Post-Transplant Colitis (ACG 2026) - Aug 29, 2026 - Abstract #P5824; Pres time: Oct 13, 2026; 10:30 AM - 04:00 PM; Location: Exhibit Halls A - D (Level 3); "Symptoms significantly improved with prednisone, vedolizumab, and ruxolitinib...He was treated with budesonide, upadacitinib, vedolizumab, infliximab, AAT, and thymoglobulin to target CD and GI GVHD...Further studies are needed to better characterize the relationship between post-transplant immune dysregulation and de novo IBD. Figure: March 2025 colonoscopy demonstrating Crohnâs Disease with active chronic ileocolitis with granulomas Figure: January 2026 colonoscopy demonstrating GI GVHD with focal ulcer and acute inflammation with increased apoptosis and focal loss of crypt"
Post-transplantation • Crohn's disease • Essential Thrombocythemia • Gastroenterology • Gastrointestinal Disorder • Genetic Disorders • Graft versus Host Disease • Hematological Disorders • Immunology • Infectious Disease • Inflammation • Inflammatory Bowel Disease • Myelofibrosis • Thrombocytosis • Transplantation
|
|
Nathan Einhorn MD 1; Elliot Berinstein MD MSc 1; Sarah Uttal MD 1; Lauren Kasmikha MD 1; Jeffrey Berinstein MD MSc 2
|